-
Fucosylation inhibitors for convenient production of fucose-deficient antibodies
Read MoreTherapeutic antibodies have revolutionized the treatment of cancers. The efficacy of many of these antibodies depends on their ability to recognize and…
-
David Vocadlo
Primary Investigator
-
-
2015
Preclinical development of a disease modifying small molecule therapy for Alzheimer disease
Read MoreDr. David Vocadlo is leading one of five BC researchers leading teams supported through the British Columbia Alzheimer’s Research Award. Established in…
-
David Vocadlo
Primary Investigator
-
-
2006
Developing and using inhibitors to examine the role of O-GlcNac post-translational modification of proteins on glucohomeostasis and beta-cell adaptation
Read MoreType 2 diabetes develops when our bodies are unable to properly regulate blood glucose levels. Normally, blood glucose levels are carefully maintained…
-
David Vocadlo
Primary Investigator
-
